Rate My Professor Silva Arslanian

Arslanian’s research examines insulin sensitivity and beta-cell function during childhood growth and development in health and disease states including obesity, prediabetes, type 2 diabetes, metabolic syndrome, and polycystic ovary syndrome, with emphasis on racial contrasts in risk. Funded by NIH, foundations, and industry, her work pioneered in vivo methods revealing accelerated beta-cell failure in youth-onset type 2 diabetes and heightened insulin resistance in obese adolescents versus adults. She contributed to consensus panels for the Endocrine Society on PCOS and childhood obesity guidelines, ADA and ISPAD on type 2 diabetes in youth, and European Society for Pediatric Endocrinology on childhood insulin resistance. With over 250 peer-reviewed publications and 50 book chapters, notable works include "Increased Lipolysis, Diminished Adipose Tissue Insulin Sensitivity and Impaired β-cell Function Relative to Adipose Tissue Insulin Sensitivity in Obese Youth with Impaired Glucose Tolerance" (Diabetes, 2017), "Adipose Tissue Insulin Resistance in Youth on the Spectrum from Normal Weight to Obese" (Diabetes Care, 2019), and new guidelines for adolescent obesity treatment in the New England Journal of Medicine (2023). Her impact is recognized by the American Diabetes Association’s Outstanding Achievement in Clinical Diabetes Research Award, ISPAD Prize for Achievement, and University of Pittsburgh Distinguished Professor title. She has chaired sessions and delivered invited lectures at national and international congresses.